PARP inhibitor AG14361, Purity ≥98%

Cat. No.: X23-10-ZQ227

PARP inhibitor AG14361, Purity ≥98%

Synonym: 328543-09-5; AG14361; AG-14361; AG 14361; Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro-; 1-(4-((Dimethylamino)methyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one; PARP inhibitor

  • MDL: MFCD18385009
  • CAS Number: 328543-09-5
  • Compound CID: 9840076
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AG14361, soluble in DMSO and insoluble in ethanol and water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks. It targets PARP1.
Molecular Weight
320.4
Molecular Formula
C19H20N4O
Targets
PARP1: <5 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 11 mg/mL (34.33 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
AG14361 can be used to study the role of PARP inhibition in enhancing radiosensitivity in cancer cells.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0